Adverum Biotechnologies, Inc. (LON:0HA3)
2.975
-0.034 (-1.12%)
At close: Sep 17, 2025
Adverum Biotechnologies Revenue
Adverum Biotechnologies had revenue of $1.00M USD in the twelve months ending June 30, 2025. In the year 2024, Adverum Biotechnologies had annual revenue of $1.00M, down -72.22%.
Revenue
$1.00M
Revenue Growth
-72.22%
P/S Ratio
60.60
Revenue / Employee
$6.45K
Employees
155
Market Cap
44.24M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.00M | -2.60M | -72.22% |
Dec 31, 2023 | 3.60M | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | 7.50M | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Shell | 198.54B |
Unilever | 51.24B |
Rolls-Royce Holdings | 19.54B |
British American Tobacco p.l.c. | 25.60B |
Rio Tinto Group | 39.22B |
BP p.l.c. | 134.89B |
Adverum Biotechnologies News
- 6 weeks ago - Adverum Biotechnologies to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 3 months ago - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Adverum Biotechnologies GAAP EPS of -$2.25 misses by $0.31 - Seeking Alpha
- 4 months ago - Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlights - GlobeNewsWire
- 4 months ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM - Accesswire
- 4 months ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM - GlobeNewsWire
- 4 months ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM - Accesswire
- 4 months ago - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire